Figure 8
From: Copper metabolism-related Genes in entorhinal cortex for Alzheimer's disease
Molecular docking pattern of the compounds identified in the DrugBank database with the corresponding targets (B2M and F2F). (A) B2M-3-indolebutyric acid [affinity (kcal/mol): − 5.4]; (B) B2M-doxycycline [affinity (kcal/mol): − 7.3]; (C) B2M-n-formylmethionine [affinity (kcal/mol): − 3.8]; (D) F2F-sirolimus [affinity (kcal/mol): − 8.2]; (E) F2F-pentosan polysulfate [affinity (kcal/mol): − 6.9]; (F) F2F-ABT-510 [affinity (kcal/mol): − 6.4]; (G) F2F-1,4-dideoxy-O2-sulfo-glucuronic acid [affinity (kcal/mol): − 8.3]; (H) F2F-1,4-dideoxy-5-dehydro-O2-sulfo -glucuronic acid [affinity (kcal/mol): − 6.0].
